Moderna
MRNA
#1155
Rank
A$28.47 B
Marketcap
A$71.80
Share price
-3.12%
Change (1 day)
73.25%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -A$4.25 Billion

According to Moderna 's latest financial reports the company's current earnings are A$1.92 Billion. , an increase over its 2024 earnings that were of -A$5.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -A$3.87 Billion-23.03%
2024 -A$5.03 Billion-8.22%
2023 -A$5.48 Billion-140.65%
2022 A$13.46 B-27.81%
2021 A$18.65 B-1911.15%
2020 -A$1.04 Billion44.7%
2019 -A$0.72 Billion28.63%
2018 -A$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$47.05 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.93 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$31.44 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$66.52 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$58.57 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.80 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$0.48 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA